SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

8.92
Delayed Data
As of Apr 20
 +0.04 / +0.45%
Today’s Change
4.51
Today|||52-Week Range
9.65
+1.83%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a -10.31% decrease from the last price of 8.92.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in SciClone Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.03
Sales
$34.0M
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -57.14%
 
 
 
 
 
 
Growthannually -10.42%
 
 
 
 
 

Sales

Growthquarterly -17.85%
 
 
 
 
 
 
Growthannually 16.11%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account